JP2005522472A - 関節炎の治療用薬剤 - Google Patents

関節炎の治療用薬剤 Download PDF

Info

Publication number
JP2005522472A
JP2005522472A JP2003581790A JP2003581790A JP2005522472A JP 2005522472 A JP2005522472 A JP 2005522472A JP 2003581790 A JP2003581790 A JP 2003581790A JP 2003581790 A JP2003581790 A JP 2003581790A JP 2005522472 A JP2005522472 A JP 2005522472A
Authority
JP
Japan
Prior art keywords
formula
acid
residue
alkyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003581790A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005522472A5 (cg-RX-API-DMAC7.html
Inventor
ソルダト,ピエロ デル
Original Assignee
ニコックス エス エイ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ニコックス エス エイ filed Critical ニコックス エス エイ
Publication of JP2005522472A publication Critical patent/JP2005522472A/ja
Publication of JP2005522472A5 publication Critical patent/JP2005522472A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2003581790A 2002-04-11 2003-03-27 関節炎の治療用薬剤 Pending JP2005522472A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002MI000773A ITMI20020773A1 (it) 2002-04-11 2002-04-11 Farmaci per il trattamento dell'artrite
PCT/EP2003/003183 WO2003084550A1 (en) 2002-04-11 2003-03-27 Drugs for the arthritis treatment

Publications (2)

Publication Number Publication Date
JP2005522472A true JP2005522472A (ja) 2005-07-28
JP2005522472A5 JP2005522472A5 (cg-RX-API-DMAC7.html) 2006-04-20

Family

ID=11449687

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003581790A Pending JP2005522472A (ja) 2002-04-11 2003-03-27 関節炎の治療用薬剤

Country Status (6)

Country Link
US (1) US20070010458A1 (cg-RX-API-DMAC7.html)
EP (1) EP1492543A1 (cg-RX-API-DMAC7.html)
JP (1) JP2005522472A (cg-RX-API-DMAC7.html)
AU (1) AU2003224002A1 (cg-RX-API-DMAC7.html)
IT (1) ITMI20020773A1 (cg-RX-API-DMAC7.html)
WO (1) WO2003084550A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003523958A (ja) 1999-12-23 2003-08-12 ニトロメド インコーポレーテッド ニトロソ化およびニトロシル化されたシクロオキシゲナーゼ−2の阻害剤、組成物ならびに使用法
US7220749B2 (en) 2002-06-11 2007-05-22 Nitromed, Inc. Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
JP2005539089A (ja) 2002-07-03 2005-12-22 ニトロメッド インコーポレーティッド ニトロソ化非ステロイド性抗炎症化合物、組成物および使用方法
US8173840B2 (en) 2003-07-29 2012-05-08 Signature R&D Holdings, Llc Compounds with high therapeutic index
US7589233B2 (en) 2003-07-29 2009-09-15 Signature R&D Holdings, Llc L-Threonine derivatives of high therapeutic index
WO2005065361A2 (en) * 2003-12-31 2005-07-21 Khosrow Kashfi Compounds and compositions for treating dysproliferative diseases, and methods of use thereof
EP1711459A4 (en) 2004-01-27 2008-01-02 Merck Frosst Company NITRIC OXIDE-FREE DIARYL-2- (5H) -FURANONES PROMOTERS AS INHIBITORS OF CYCLOOXYGENASE-2
CA2554333A1 (en) 2004-01-27 2005-08-04 Merck Frosst Company Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
AU2005281359A1 (en) 2004-08-26 2006-03-16 Apparao Satyam Prodrugs and codrugs containing novel bio-cleavable disulfide linkers
TW200616604A (en) 2004-08-26 2006-06-01 Nicholas Piramal India Ltd Nitric oxide releasing prodrugs containing bio-cleavable linker
US7586003B2 (en) * 2005-07-14 2009-09-08 Zinpro Corporation Derivatives of seleno-amino acids
WO2009023631A1 (en) 2007-08-10 2009-02-19 Basil Rigas Anti-inflammatory compounds and uses thereof
EP2188245B1 (en) 2007-08-17 2013-11-06 Council of Scientific & Industrial Research Nitric oxide releasing derivatives of paracetamol
US9844599B2 (en) 2013-01-21 2017-12-19 Apparao Satyam Nitric oxide releasing produgs of therapeutic agents
CN108864008B (zh) * 2017-05-09 2021-10-22 江苏康缘药业股份有限公司 一种橙酮类化合物及其制备方法与应用
CN111116529A (zh) * 2020-01-13 2020-05-08 江苏康缘药业股份有限公司 一种具有抗炎作用的化合物及其制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2998450A (en) * 1958-05-19 1961-08-29 Warner Lambert Pharmaceutical Process of preparing nu-acetyl-p-amino phenol
AT290523B (de) * 1962-01-05 1971-06-11 Merck & Co Inc Verfahren zur Herstellung neuer α-(3-Indolyl)-carbonsäuren
US3600437A (en) * 1969-05-28 1971-08-17 Lilly Co Eli Substituted phenylalkanoic acids and derivatives thereof
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
US3784701A (en) * 1970-09-21 1974-01-08 American Cyanamid Co Compositions containing substituted benzoylpropionic acids and method of use to treat inflammation and pain
US3843681A (en) * 1971-06-01 1974-10-22 American Home Prod 1-carboxamido pyrano(thiopyrano)(3,4-6)indole derivatives
US4035376A (en) * 1972-10-24 1977-07-12 Janssen Pharmaceutica N.V. Aroyl-substituted phenylacetic acid derivatives
US3997669A (en) * 1972-12-26 1976-12-14 Ciba-Geigy Corporation Tertiary aminoacids
US4061779A (en) * 1973-09-11 1977-12-06 Beecham Group Limited Naphthalene derivatives having anti-inflammatory activity
US4161538A (en) * 1977-04-05 1979-07-17 Sankyo Company Limited Substituted phenylacetic acid derivatives and process for the preparation thereof
IT1256450B (it) * 1992-11-26 1995-12-05 Soldato Piero Del Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
RU2145595C1 (ru) * 1994-05-10 2000-02-20 Никокс С.А. Нитроксисоединения и фармацевтическая композиция на их основе, имеющие противовоспалительную, анальгетическую и антитромбоцитарную активности
DE4420523A1 (de) * 1994-06-13 1995-12-14 Cassella Ag Verwendung von NO-freisetzenden Verbindungen zur Behandlung und Vorbeugung von systemischen Entzündungssyndromen
WO2002026748A2 (en) * 2000-09-25 2002-04-04 The Procter & Gamble Company Metal complexes for use in medical and therapeutic applications
WO2002074238A2 (en) * 2001-02-16 2002-09-26 Lavipharm Laboratories Inc. Water soluble and palatable complexes

Also Published As

Publication number Publication date
US20070010458A1 (en) 2007-01-11
ITMI20020773A0 (it) 2002-04-11
ITMI20020773A1 (it) 2003-10-13
WO2003084550A1 (en) 2003-10-16
EP1492543A1 (en) 2005-01-05
AU2003224002A1 (en) 2003-10-20

Similar Documents

Publication Publication Date Title
JP5876435B2 (ja) 骨髄腫の処置のためのhdac阻害剤の使用
US20070010458A1 (en) Drugs for the arthritis treatment
KR20070099527A (ko) 유기 화합물의 조합물
EP0741567A1 (en) Inhibition of smooth muscle migration and proliferation with hydroxy carbazole compounds
JPH09512798A (ja) 消炎、鎮痛および抗血栓活性を有するニトロ化合物およびそれらの組成物
JP2002524415A (ja) 炎症を治療するための医薬組成物及び方法
US20060183787A1 (en) Methods of the treatment of psoriatic arthritis using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
JP2005522472A5 (cg-RX-API-DMAC7.html)
EP2121020A2 (en) Tgf-beta stimulant and further agent to reduce side effects
TW201811372A (zh) 利用fxr促效劑之方法
JP2004509145A (ja) リウマチ性疾患の治療薬を製造するためのr−アリールプロピオン酸の使用
KR101722432B1 (ko) 류마티스성 관절염 등 자가면역 질환 치료의 개선방법
JPH10511978A (ja) アルツハイマー病の治療用薬剤
US4559326A (en) Antiinflammatory compositions and methods
US20070197602A1 (en) Combined pharmaceutical composition
CA2698377A1 (en) Piperidinylamino-thieno[2,3-d] pyrimidine compounds for treating fibrosis
AU2007336077A1 (en) New combination for use in the treatment of inflammatory disorders
JPWO2005028453A1 (ja) フェニル酢酸誘導体、その製造方法および用途
RU2160102C2 (ru) Применение бензидамина для лечения патологических состояний, вызванных фно
CN1681533A (zh) 用于治疗动脉硬化的药用组合物
JP2005068035A (ja) 慢性疼痛治療用外用剤
WO2008098957A1 (en) Use of condensed pyrimidine derivatives for the treatment of autoimmune and inflammatory diseases
WO2016089814A1 (en) Deuterated analogues of daclatasvir
KR20210015849A (ko) 트로피펙소르 및 세니크리비록을 포함하는 조합물
JP2004331660A (ja) 医薬組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060302

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060302

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090929

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20091225

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100107

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100128

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100223